马保健市场规模、份额和趋势分析报告:按产品(药物、疫苗)、适应症、活动、分销渠道、地区、细分市场预测 2022-2030 年
市场调查报告书
商品编码
1147601

马保健市场规模、份额和趋势分析报告:按产品(药物、疫苗)、适应症、活动、分销渠道、地区、细分市场预测 2022-2030 年

Equine Healthcare Market Size, Share & Trends Analysis Report By Product (Pharmaceuticals, Vaccines), By Indication, By Activity, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

马匹健康管理市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告,到 2030 年,全球马匹保健市场预计将达到 43.7 亿美元。从 2022 年到 2030 年,该市场预计将以 6.1% 的复合年增长率增长。产品研发的增加、对马诊断的需求、主要行业利益相关者的投资、马疾病患病率上升等是推动市场增长的一些关键因素。例如,2021 年 9 月,美国农业部在动物营养和健康方面投资了约 30 亿美元。

COVID-19 大流行对赛马/体育行业产生了特别显着的影响。马匹护理服务的减少导致马术表演被取消。由于 COVID-19,所有教育、培训、比赛、活动、旅游相关和娱乐活动都已取消。赛马在全球范围内受到影响,对马厩的需求减少。瑞典是欧盟唯一一个继续赛马的国家。法国马业集群Hippolia进行的一项调查发现,68.8%的受访者认为无法弥补缺口,所有马术比赛都已取消。运动马的损失总额估计为 3.8589 亿美元。然而,放宽限制措施和改善马匹医疗保健的可及性将使市场在 2021 年復苏。

技术进步、研究和开发以及市场参与者在马匹诊断方面不断增加的举措是推动市场发展的主要因素。例如,根据美国兽医协会 2022 年 7 月发表的一篇文章,一项研究评估了专有的基于螺旋扇束 CT 的诊断性能,该 CT 用于对患有临床头颈并发症的马进行成像。总共包括 120 多匹马,并审查了在两家大学医院接受头颈部 CT 扫描的马的病历。年龄、性别、品种、主诉、镇静剂剂量、手术时间、附加成像技术的使用、成像、临床诊断和成像相关问题都被记录下来。该 CT 系统已被证明在马牙齿和鼻窦的常规成像中具有短期和可靠的实用性。

此外,马类疾病的增加也是推动市场增长的因素之一。例如,西尼罗河病毒于 2022 年 9 月被加利福尼亚州食品和农业部确认在稻田的一头来自内华达县的 10 岁未接种疫苗的夸特马种马呈阳性反应,该种马錶现出短暂的发烧和神经系统症状。这是 2022 年在加利福尼亚州确认的第八例马 WNV 病例。其他六个县也确认了阳性病例:克恩 3 个,内华达州 1 个,萨克拉门托 1 个,圣路易斯奥比斯波 1 个,特哈马 1 个,丘利亚 3 个。预计未来对马类疾病的认识会提高,及时接种疫苗的需求也会增加。

马匹健康管理市场报告要点

按产品划分,2021年医药板块占比将超过30.0%,渗透率高、应用广泛,将占据市场主导地位

其他产品领域,包括再生医学和干细胞治疗解决方案,预计在预测期内增长最快

根据指示,寄生虫控制将在 2021 年占据最大份额,超过 20.0%。这是由于对控制内部和外部寄生虫的有效杀寄生虫剂的需求不断增长

体育/赛车活动领域预计将在 2021 年以超过 40.0% 的收入份额主导市场,在预测期内以最快的速度增长

从分销渠道来看,动物医院和诊所在 2021 年所占份额最大。电子商务领域预计在预测期内以最快的复合年增长率增长

北美和欧洲在 2021 年占据了显着份额。由于马术比赛/体育行业的发展,预计亚太地区在预测期内将呈现良好增长。

内容

第 1 章调查方法及范围

  • 市场细分和范围
    • 估计/预测时间表
  • 调查方法
  • 资讯采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
    • 初步调查的详细资讯
  • 资讯或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
  • 二级资讯列表

第 2 章执行摘要

  • 市场展望
  • 细分市场展望

第 3 章马保健市场可变趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 辅助市场展望
  • 按适应症绘製渗透率和增长前景,2021 年
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 行业分析 - 搬运工
    • 波特的分析
      • 供应商的议价能力
      • 买家的议价能力
      • 替代品的威胁
      • 新进入者的威胁
      • 竞争公司之间的敌对关係
    • PESTLE 分析
      • 政治/法律状况
      • 经济状况
      • 社交情况
      • 技术概况
  • 2017-2021 年估计的马匹数量,按主要国家/地区分类
  • 监管框架和赎回情况
  • 价格分析
  • 主要地区的疾病流行率估计分析
  • 马匹保健:COVID-19 的影响
    • 当前和未来的影响分析
    • COVID-19 对市场参与者的影响

第 4 章马保健市场:细分分析,副产品,2017-2030(百万美元)

  • 2021 年和 2030 年产品市场份额分析
  • 马保健市场:产品差异分析
  • 疫苗
  • 医药
    • 杀寄生虫剂
    • 抗感染
    • 消炎镇痛药
    • 其他
  • 药用饲料添加剂
  • 诊断
  • 软件和服务
  • 其他

第 5 章马保健市场:细分分析,按适应症,2017-2030 年(百万美元)

  • 2021 年和 2030 年适应症市场份额分析
  • 马匹健康管理市场:适应症变化分析
  • 肌肉骨骼疾病
  • 寄生虫控制
  • 内科
  • 马疱疹病毒
  • 马脑脊髓炎
  • 马流感
  • 西尼罗病毒
  • 破伤风
  • 其他

第 6 章马保健市场:细分分析,按活动,2017-2030 年(百万美元)

  • 2021 年和 2030 年活动市场份额分析
  • 马匹健康管理市场:活动变化分析
  • 运动/赛车
  • 娱乐
  • 其他

第 7 章马保健市场:细分分析,按分销渠道,2017-2030 年(百万美元)

  • 2021 年和 2030 年分销渠道市场份额分析
  • 马匹健康管理市场:分销渠道分析波动分析
  • 兽医医院和诊所
  • 电子商务
  • 其他

第 8 章马保健市场:区域市场分析、副产品、适应症、活动和分销渠道 2017-2030(百万美元)

  • 2021 年和 2030 年区域市场份额分析
  • 区域市场概况
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯

第 9 章马匹健康管理市场-竞争格局

  • 公司简介
    • Zoetis
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • Boehringer Ingelheim International GmbH
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • Ceva
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • SOUND
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • MERCK & CO., INC.
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • Hallmarq Veterinary Imaging
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • ESAOTE SPA
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • Vetoquinol S.A.
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • IDEXX Laboratories, Inc.
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
    • Dechra Pharmaceuticals PLC
      • 公司简介
      • 财务业绩
      • 产品/服务基准
      • 战略举措
  • 市场参与分类
  • 公司市场分析 - 热图分析
  • 协同分析:主要交易和战略联盟
  • 主要公司名单
Product Code: GVR-4-68039-986-8

Equine Healthcare Market Growth & Trends:

The global equine healthcare market size is anticipated to reach USD 4.37 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.

The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.

Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses.

Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.

Equine Healthcare Market Report Highlights:

  • Based on product, the pharmaceuticals segment dominated the market with a share of over 30.0% in 2021 owing to a high uptake and wide availability of these products
  • The others product segment comprising regenerative medicine and stem cell therapy solutions is projected to be the fastest growing segment in the forecast period
  • Based on indication, parasite control held the largest share of over 20.0% in 2021. It is due to the growing demand for effective parasiticides for the control of internal and external parasites
  • The sports/racing activity segment dominated the market with a revenue share of over 40.0% in 2021 and is anticipated to grow at the fastest rate during the forecast period
  • Based on distribution channel, veterinary hospitals and clinics held the largest share in 2021. The e-commerce segment is projected to expand at the fastest CAGR during the forecast period
  • North America and Europe held notable shares in 2021. The Asia Pacific is expected to witness lucrative growth in the forecast period owing to a budding equine racing/ sports sector

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
  • 1.7 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Equine Healthcare Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping by Indication, 2021
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
  • 3.4 Industry Analysis - Porter's
    • 3.4.1 Porter's Analysis
      • 3.4.1.1 Bargaining Power Of Suppliers
      • 3.4.1.2 Bargaining Power Of Buyers
      • 3.4.1.3 Threat Of Substitutes
      • 3.4.1.4 Threat Of New Entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 Pestle Analysis
      • 3.4.2.1 Political/Legal Landscape
      • 3.5.2.2 Economic Landscape
      • 3.5.2.3 Social Landscape
      • 3.5.2.4 Technology Landscape
  • 3.5 Estimated Equine Population, 2017 to 2021, by key countries
  • 3.6 Regulatory Framework & Reimbursement Landscape
  • 3.7 Pricing Analysis
  • 3.8 Estimated Disease Prevalence Analysis, By Key Regions
  • 3.9 Equine Healthcare: Covid-19 Impact
    • 3.9.1 Current And Future Impact Analysis
    • 3.9.2 Impact Of Covid-19 On Market Players

Chapter 4 Equine Healthcare Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)

  • 4.1 Product Market Share Analysis, 2021 & 2030
  • 4.2 Equine Healthcare market: Product movement analysis
  • 4.3 Vaccines
    • 4.3.1 Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.4 Pharmaceuticals
    • 4.4.1 Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.2 Parasiticides
      • 4.4.2.1 Parasiticides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.3 Anti-Infectives
      • 4.4.3.1 Anti-Infectives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.4 Anti-Inflammatory & Analgesics
      • 4.4.4.1 Anti-Inflammatory & Analgesics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.5 Others
      • 4.4.5.1 Other Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.5 Medicinal Feed Additives
    • 4.5.1 Medicinal Feed Additives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.6 Diagnostics
    • 4.6.1 Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.7 Software & Services
      • 4.7.1software & Services Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1. Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 5 Equine Healthcare Market: Segment Analysis, By Indication, 2017 - 2030 (USD Million)

  • 5.1 Indication Market Share Analysis, 2021 & 2030
  • 5.2 Equine Healthcare market: Indication movement analysis
  • 5.3 Musculoskeletal Disorders
    • 5.3.1 Musculoskeletal Disorders Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.4 Parasite Control
    • 5.4.1 Parasite Control Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.5 Internal Medicine
    • 5.5.1 Internal Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.6 Equine Herpes Virus
    • 5.6.1 Equine Herpes Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.7 Equine Encephalomyelitis
    • 5.7.1 Equine Encephalomyelitis Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.8 Equine Influenza
    • 5.8.1 Equine Influenza Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.9 West Nile Virus
    • 5.9.1 West Nile Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.10 Tetanus
    • 5.10.1 Tetanus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.11 Others
    • 5.11.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 6 Equine Healthcare Market: Segment Analysis, By Activity, 2017 - 2030 (USD Million)

  • 6.1 Activity Market Share Analysis, 2021 & 2030
  • 6.2 Equine Healthcare market: Activity movement analysis
  • 6.3 Sports/Racing
    • 6.3.1 Sports/Racing Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 6.4 Recreation
    • 6.4.1 Recreation Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 7 Equine Healthcare Market: Segment Analysis, By Distribution Channel, 2017 - 2030 (USD Million)

  • 7.1 Distribution Channel Market Share Analysis, 2021 & 2030
  • 7.2 Equine Healthcare Market: Distribution Channel Analysis Movement Analysis
  • 7.3 Veterinary Hospitals & Clinics
    • 7.3.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 7.4 E-Commerce
    • 7.4.1 E-Commerce Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 8 Equine Healthcare Market: Regional Market Analysis, By Product, Indication, Activity, and Distribution Channel 2017 - 2030 (USD Million)

  • 8.1 Regional Market Share Analysis, 2021 & 2030
  • 8.2 Regional Market Snapshot
  • 8.3 North America
    • 8.3.1 North America Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe Equine Healthcare Market Estimates and Forecasts By Countries, 2017 - 2030 (USD MILLION)
    • 8.4.2 U.K.
      • 8.4.2.1 U.K. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.4.3 Germany
      • 8.4.3.1 Germany Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.4.4 France
      • 8.4.4.1 France Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.4.5 Italy
      • 8.4.5.1 Italy Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.4.6 Spain
      • 8.4.6.1 Spain Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.5.2 Japan
      • 8.5.2.1 Japan Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.5.3 China
      • 8.5.3.1 China Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.4 India
      • 8.5.4.1 India Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.5.5 Australia
      • 8.5.5.1 Australia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.6 South Korea
      • 8.5.6.1 South Korea Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Brazil Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.6.3 Mexico
      • 8.6.3.1 Mexico Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.7 MEA
    • 8.7.1 MEA Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.7.2 Saudi Arabia
      • 8.7.2.1 Saudi Arabia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 9Equine Healthcare Market - Competitive Landscape

  • 9.1 Company Profiles
    • 9.1.1 Zoetis
      • 9.1.1.1 Company Overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product/Service Benchmarking
      • 9.1.1.4 Strategic Initiatives
    • 9.1.2 Boehringer Ingelheim International GmbH
      • 9.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product/Service Benchmarking
      • 9.1.2.4 Strategic Initiatives
    • 9.1.3 Ceva
      • 9.1.3.1 Company Overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product/Service Benchmarking
      • 9.1.3.4 Strategic Initiatives
    • 9.1.4 SOUND
      • 9.1.4.1 Company Overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product/Service Benchmarking
      • 9.1.4.4 Strategic Initiatives
    • 9.1.5 MERCK & CO., INC.
      • 9.1.5.1 Company Overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product/Service Benchmarking
      • 9.1.5.4 Strategic Initiatives
    • 9.1.6 Hallmarq Veterinary Imaging
      • 9.1.6.1 Company Overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product/Service Benchmarking
      • 9.1.6.4 Strategic Initiatives
    • 9.1.7 ESAOTE SPA
      • 9.1.7.1 Company Overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product/Service Benchmarking
      • 9.1.7.4 Strategic Initiatives
    • 9.1.8 Vetoquinol S.A.
      • 9.1.8.1 Company Overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product/Service Benchmarking
      • 9.1.8.4 Strategic Initiatives
    • 9.1.9 IDEXX Laboratories, Inc.
      • 9.1.9.1 Company Overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product/Service Benchmarking
      • 9.1.9.4 Strategic Initiatives
    • 9.1.10 Dechra Pharmaceuticals PLC
      • 9.1.10.1 Company Overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product/Service Benchmarking
      • 9.1.10.4 Strategic Initiatives
  • 9.2 Market Participation Categorization
  • 9.3 Company Market Position Analysis - Heat Map Analysis
  • 9.4 Synergy Analysis: Major Deals & Strategic Alliances
  • 9.5 List of Key Companies

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Key Companies
  • Table 3 North America Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 4 North America Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 5 North America Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 6 North America Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 7 North America Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 8 U.S. Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 9 U.S. Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 10 U.S. Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 11 U.S. Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 12 Canada Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 13 Canada Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 14 Canada Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 15 Canada Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 16 Europe Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 17 Europe Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 18 Europe Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 19 Europe Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 20 Europe Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 21 U.K. Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 22 U.K. Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 23 U.K. Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 24 U.K. Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 25 Germany Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 26 Germany Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 27 Germany Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 28 Germany Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 29 France Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 30 France Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 31 France Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 32 France Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 33 Italy Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 34 Italy Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 35 Italy Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 36 Italy Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 37 Spain Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 38 Spain Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 39 Spain Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 40 Spain Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 41 Asia Pacific Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 42 Asia Pacific Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 43 Asia Pacific Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 44 Asia Pacific Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 45 Asia Pacific Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 46 China Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 47 China Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 48 China Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 49 China Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 50 Japan Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 51 Japan Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 52 Japan Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 53 Japan Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 54 India Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 55 India Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 56 India Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 57 India Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 58 Australia Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 59 Australia Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 60 Australia Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 61 Australia Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 62 South Korea Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 63 South Korea Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 64 South Korea Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 65 South Korea Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 66 Latin America Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 67 Latin America Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 68 Latin America Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 69 Latin America Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 70 Latin America Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 71 Brazil Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 72 Brazil Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 73 Brazil Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 74 Brazil Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 75 Mexico Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 76 Mexico Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 77 Mexico Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 78 Mexico Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 79 Argentina Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 80 Argentina Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 81 Argentina Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 82 Argentina Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 83 MEA Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 84 MEA Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 85 MEA Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 86 MEA Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 87 MEA Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 88 South Africa Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 89 South Africa Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 90 South Africa Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 91 South Africa Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 92 Saudi Arabia Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 93 Saudi Arabia Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 94 Saudi Arabia Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 95 Saudi Arabia Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 96 Global Equine Healthcare market, by region, 2017 - 2030 (USD Million)
  • Table 97 Global Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 98 Global Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 99 Global Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 100 Global Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 101 Global Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 102 North America Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 103 U.S. Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 104 Canada Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 105 Europe Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 106 U.K. Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 107 Germany Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 108 France Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 109 Italy Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 110 Spain Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 111 Asia Pacific Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 112 Japan Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 113 China Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 114 India Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 115 Australia Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 116 South Korea Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 117 Latin America Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 118 Brazil Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 119 Mexico Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 120 Argentina Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 121 MEA Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 122 South Africa Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 123 Saudi Arabia Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Equine Healthcare Market Revenues, 2021, (USD Millions)
  • Fig. 11 Parent market outlook
  • Fig. 12 Ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping by activity, 2021
  • Fig. 14 Market trends & outlook
  • Fig. 15 Market driver relevance analysis
  • Fig. 16 Market restraint relevance analysis
  • Fig. 17 Equine Healthcare market Product outlook: Key takeaways
  • Fig. 18 Equine Healthcare market: Product movement analysis
  • Fig. 19 Global Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 20 Global Pharmaceuticals market, 2017 - 2030 (USD Million)
  • Fig. 21 Global Parasiticides market, 2017 - 2030 (USD Million)
  • Fig. 22 Global Anti-infectives market, 2017 - 2030 (USD Million)
  • Fig. 23 Global Anti-inflammatory & Analgesics market, 2017 - 2030 (USD Million)
  • Fig. 24 Global Other Pharmaceuticals market, 2017 - 2030 (USD Million)
  • Fig. 25 Global Medicinal Feed Additives market, 2017 - 2030 (USD Million)
  • Fig. 26 Global Diagnostics market, 2017 - 2030 (USD Million)
  • Fig. 27 Global Software & Services market, 2017 - 2030 (USD Million)
  • Fig. 28 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 29 Equine Healthcare market Indication outlook: Key takeaways
  • Fig. 30 Equine Healthcare market: Indication movement analysis
  • Fig. 31 Global Musculoskeletal Disorders market, 2017 - 2030 (USD Million)
  • Fig. 32 Global Parasite Control market, 2017 - 2030 (USD Million)
  • Fig. 33 Global Internal Medicine market, 2017 - 2030 (USD Million)
  • Fig. 34 Global Equine Herpes virus market, 2017 - 2030 (USD Million)
  • Fig. 35 Global Equine Encephalomyelitis market, 2017 - 2030 (USD Million)
  • Fig. 36 Global Equine Influenza market, 2017 - 2030 (USD Million)
  • Fig. 37 Global West Nile Virus market, 2017 - 2030 (USD Million)
  • Fig. 38 Global Tetanus market, 2017 - 2030 (USD Million)
  • Fig. 39 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 40Equine Healthcare market Activity outlook: Key takeaways
  • Fig. 41Equine Healthcare market: Activity movement analysis
  • Fig. 42 Global Sports/Racing market, 2017 - 2030 (USD Million)
  • Fig. 43 Global Recreation market, 2017 - 2030 (USD Million)
  • Fig. 44 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 45 Equine Healthcare market Distribution Channel outlook: Key takeaways
  • Fig. 46 Equine Healthcare market: Distribution Channel movement analysis
  • Fig. 47 Global Veterinary Hospitals & Clinics market, 2017 - 2030 (USD Million)
  • Fig. 48 Global E-Commerce market, 2017 - 2030 (USD Million)
  • Fig. 49 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 50 Regional outlook, 2021 & 2030
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 53 U.S. Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 54 Canada Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 55 Europe Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 56 U.K. Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 57 Germany Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 58 France Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 59 Italy Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 60 Spain Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 61 Asia Pacific Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 62 Japan Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 63 China Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 64 India Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 65 Australia Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 66 South Korea Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 67 Latin America Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 68 Brazil Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 69Mexico Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 70 Argentina Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 71 MEA Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 72 South Africa Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 74 Market Participant Categorization
  • Fig. 75 Equine Healthcare: Heat Map Analysis